Title : Preclinical emergence of vandetanib as a potent antitumour agent in mesothelioma: molecular mechanisms underlying its synergistic interaction with pemetrexed and carboplatin.

Pub. Date : 2011 Nov 8

PMID : 21970874






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Vandetanib significantly downregulated epidermal growth factor receptor (EGFR)/Erk/Akt phosphorylation as well as E2F-1 mRNA and TS mRNA/protein levels. vandetanib AKT serine/threonine kinase 1 Homo sapiens